search
Back to results

A TargEted MAnageMent Intervention for Reducing Stroke Risk Factors in High Risk Ugandans (TEAM-U)

Primary Purpose

Stroke

Status
Active
Phase
Not Applicable
Locations
Uganda
Study Type
Interventional
Intervention
TEAM
ETAU
Sponsored by
Case Western Reserve University
About
Eligibility
Locations
Arms
Outcomes
Full info

About this trial

This is an interventional treatment trial for Stroke focused on measuring Stroke

Eligibility Criteria

18 Years - undefined (Adult, Older Adult)All SexesDoes not accept healthy volunteers

Inclusion Criteria:

  • Age range: ≥ 18 years
  • At risk for stroke defined by the following:

    1. High systolic BP defined as >140 mmHg assessed on at least 2 occasions at least 3 days apart and either criterion b or c as noted below:
    2. At least 1 other modifiable stroke risk factor including: diabetes, hyperlipidemia, obesity, smoking, problem alcohol use or sedentary lifestyle. Problem alcohol use for screening purposes will be assessed with questions on frequency, type of alcohol and quantity consumed. Participants will be classified as engaging in potential problem alcohol use if they exceed the recommended level for safe alcohol intake i.e. more than 3 drinks on average every time they drink, or if they undertook binge drinking (i.e. more than 3 drinks on one occasion in the one month preceding the evaluation).
    3. History of stroke or transient ischemic attack within the past 5 years
  • Able to participate in group sessions

Exclusion Criteria:

  • Individuals who are unable or unwilling to provide written informed consent
  • Individuals who have sickle-cell disease
  • Females who are pregnant or lactating
  • Individuals with dementia

Sites / Locations

  • Mulago Hospital
  • Nsambya Hospital
  • Mbarara Regional Referral Hospital

Arms of the Study

Arm 1

Arm 2

Arm Type

Experimental

Active Comparator

Arm Label

TargEted MAnageMent Intervention (TEAM)

Enhanced treatment as usual (ETAU)

Arm Description

This arm will receive the experimental intervention, TargEted MAnageMent Intervention (TEAM)

This arm will receive the control intervention, Enhanced Treatment as Usual (ETAU).

Outcomes

Primary Outcome Measures

Change from baseline systolic blood pressure (BP) at 6 months
Systolic blood pressure indicates how much pressure your blood is exerting against your artery walls when the heart beats. Higher reading implies more pressure

Secondary Outcome Measures

Full Information

First Posted
December 22, 2020
Last Updated
September 25, 2023
Sponsor
Case Western Reserve University
Collaborators
National Institute of Neurological Disorders and Stroke (NINDS), Fogarty International Center of the National Institute of Health
search

1. Study Identification

Unique Protocol Identification Number
NCT04685408
Brief Title
A TargEted MAnageMent Intervention for Reducing Stroke Risk Factors in High Risk Ugandans
Acronym
TEAM-U
Official Title
A TargEted MAnageMent Intervention for Reducing Stroke Risk Factors in High Risk
Study Type
Interventional

2. Study Status

Record Verification Date
September 2023
Overall Recruitment Status
Active, not recruiting
Study Start Date
May 13, 2022 (Actual)
Primary Completion Date
March 30, 2025 (Anticipated)
Study Completion Date
March 30, 2025 (Anticipated)

3. Sponsor/Collaborators

Responsible Party, by Official Title
Principal Investigator
Name of the Sponsor
Case Western Reserve University
Collaborators
National Institute of Neurological Disorders and Stroke (NINDS), Fogarty International Center of the National Institute of Health

4. Oversight

Studies a U.S. FDA-regulated Drug Product
No
Studies a U.S. FDA-regulated Device Product
No
Data Monitoring Committee
Yes

5. Study Description

Brief Summary
The proposed 2-phase project will first refine the TargetEd MAnageMent (TEAM) intervention to ensure acceptability across a broad range of Ugandans at risk for stroke and then test the effects of TEAM in reducing stroke risk in a 3-site, prospective, 6-month randomized controlled trial (RCT).
Detailed Description
In Phase 1 of the project, stakeholder's advisory board (SAB) will be convened across 3 Ugandan sites. The SAB will be composed of up to 15 relevant stakeholders including 3 stroke survivors, 3 individuals with multiple stroke risk factors as defined above, 3 family members, 3 clinicians and 3 administrators who practice in the proposed study enrollment sites. The purpose of the SAB is to refine the TEAM intervention content to meet the needs of patients and professional healthcare stakeholders and suggest how TEAM might best be incorporated into clinical workflow, as well as give guidance and feedback on recruitment methods and advertisements. Phase 2 of the project will be conducted across 3 Ugandan sites that will enroll a representative sample of Ugandans at risk for stroke (Kiruddu, Nsambya and Mbarara Hospitals and their associated outpatient clinics). In the RCT portion of the study, 246 participants will be randomized at baseline on a 1:1 basis to receive either TEAM (N= 123) or enhanced treatment as usual (ETAU) (N=123) and will be followed for a total of 6 months. Since stroke is a moderately long-term health outcome (years to decades) that typically occurs in the presence of one or more stroke risk factors, the project will focus on testing whether TEAM can modify well-established short-term biomarkers that predict stroke risk, specifically BP control, serum cholesterol and blood glucose control. Secondary outcomes of interest include additional stroke risk biomarkers, (HDL, LDL, triglycerides) diet, exercise, use of alcohol and tobacco, stroke knowledge/attitudes, stress, and treatment adherence with risk-reducing medications. We will also explore associations of age, gender, urban vs. rural residential status and stroke history (prior vs. no previous stroke) on TEAM outcomes. To help inform future scale-up should RCT findings be positive, we will assess barriers and facilitators to TEAM implementation using both qualitative and quantitative methods.

6. Conditions and Keywords

Primary Disease or Condition Being Studied in the Trial, or the Focus of the Study
Stroke
Keywords
Stroke

7. Study Design

Primary Purpose
Treatment
Study Phase
Not Applicable
Interventional Study Model
Parallel Assignment
Masking
None (Open Label)
Allocation
Randomized
Enrollment
246 (Actual)

8. Arms, Groups, and Interventions

Arm Title
TargEted MAnageMent Intervention (TEAM)
Arm Type
Experimental
Arm Description
This arm will receive the experimental intervention, TargEted MAnageMent Intervention (TEAM)
Arm Title
Enhanced treatment as usual (ETAU)
Arm Type
Active Comparator
Arm Description
This arm will receive the control intervention, Enhanced Treatment as Usual (ETAU).
Intervention Type
Behavioral
Intervention Name(s)
TEAM
Intervention Description
TEAM is informed by principles of social cognitive theory TEAM uses nurses and peer educator dyads (PEDs) composed of patients and their care partners to co-deliver an intervention intended to help reduce future stroke risk. Team begins with one 60-minute 1:1 orientation session, in which the nurse and PED meet with the patient and his/her care partner. This is followed by 6 hour-long group sessions with 6-8 patients and their care partners held approximately weekly. The first orientation session will be done approximately 1 week post baseline, followed by group sessions were done at 2, 4, 6, 8, 10 and 12 weeks post-baseline.
Intervention Type
Behavioral
Intervention Name(s)
ETAU
Intervention Description
ETAU will consist of an orientation visit with a nurse who will provide patient-education materials on stroke risk adapted from the American Heart Association materials and cover common risk factors such as hypertension, obesity, high salt/high fat diet and diabetes. Patients will also receive basic written information in their language of preference and tailored to the reading level of most patients at the clinic. Patients will be offered the opportunity to bring a family member with them to this visit who may also ask questions and who can assist them with understanding written materials for those with limited literacy. The nurse in ETAU will then follow-up with participants with a series of 9 brief phone calls spaced out over the course of 6 months (approximately every 2 weeks during months 1 and 2, then approximately monthly thereafter). Content will reinforce materials provided in the orientation visit and the nurse will be available to answer questions that may arise.
Primary Outcome Measure Information:
Title
Change from baseline systolic blood pressure (BP) at 6 months
Description
Systolic blood pressure indicates how much pressure your blood is exerting against your artery walls when the heart beats. Higher reading implies more pressure
Time Frame
Baseline and 6 months

10. Eligibility

Sex
All
Minimum Age & Unit of Time
18 Years
Accepts Healthy Volunteers
No
Eligibility Criteria
Inclusion Criteria: Age range: ≥ 18 years At risk for stroke defined by the following: High systolic BP defined as ≥ 140 mmHg assessed on at least 2 occasions at least 3 days apart and either criterion b or c as noted below: At least 1 other modifiable stroke risk factor including: diabetes, hyperlipidemia, obesity, smoking, problem alcohol use or sedentary lifestyle. Problem alcohol use for screening purposes will be assessed with questions on frequency, type of alcohol and quantity consumed. Participants will be classified as engaging in potential problem alcohol use if they exceed the recommended level for safe alcohol intake i.e. more than 3 drinks on average every time they drink, or if they undertook binge drinking (i.e. more than 3 drinks on one occasion in the one month preceding the evaluation). History of stroke or transient ischemic attack within the past 5 years Able to participate in group sessions Exclusion Criteria: Individuals who are unable or unwilling to provide written informed consent Individuals who have sickle-cell disease Females who are pregnant or lactating Individuals with dementia
Overall Study Officials:
First Name & Middle Initial & Last Name & Degree
Marta Sajatovic, MD
Organizational Affiliation
Case Western Reserve University
Official's Role
Principal Investigator
Facility Information:
Facility Name
Mulago Hospital
City
Kampala
Country
Uganda
Facility Name
Nsambya Hospital
City
Kampala
Country
Uganda
Facility Name
Mbarara Regional Referral Hospital
City
Mbarara
Country
Uganda

12. IPD Sharing Statement

Plan to Share IPD
Yes
IPD Sharing Plan Description
The final dataset will include self-reported demographic and behavioral data from interviews with the subjects' data. The final dataset will be stripped of identifiers prior to release for sharing; we believe that there remains the possibility of deductive disclosure of subjects with unusual characteristics. Thus, we will make the data and associated documentation available to users only under a data-sharing agreement (national and international are required) that provides for: (1) a commitment to using the data only for research purposes and not to identify any individual participant; (2) a commitment to securing the data using appropriate computer technology; and (3) a commitment to destroying or returning the data after analyses are completed. Beyond this all the information generated from the various study data sets will be made available to the global community in open access journals indexed in pub med or via the internet as described in the dissemination plan.
Citations:
PubMed Identifier
34157024
Citation
Kaddumukasa M, Najjuma J, Mbalinda SN, Kaddumukasa MN, Nakibuuka J, Burant C, Moore S, Blixen C, Katabira ET, Sajatovic M. Reducing stroke burden through a targeted self-management intervention for reducing stroke risk factors in high-risk Ugandans: A protocol for a randomized controlled trial. PLoS One. 2021 Jun 22;16(6):e0251662. doi: 10.1371/journal.pone.0251662. eCollection 2021.
Results Reference
derived

Learn more about this trial

A TargEted MAnageMent Intervention for Reducing Stroke Risk Factors in High Risk Ugandans

We'll reach out to this number within 24 hrs